Hughes Steven George 4
4 · Avidity Biosciences, Inc. · Filed Sep 23, 2025
Insider Transaction Report
Form 4
Hughes Steven George
Chief Medical Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2025-09-22−2,208→ 70,667 totalExercise: $10.16Exp: 2034-01-19→ Common Stock (2,208 underlying) - Sale
Common Stock
2025-09-22$40.58/sh−2,208$89,601→ 38,867 total - Exercise/Conversion
Common Stock
2025-09-22$10.16/sh+2,208$22,433→ 41,075 total
Footnotes (2)
- [F1]The exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 12, 2024.
- [F2]This option was granted on January 20, 2024 and vests in equal installments of 2,208 shares on each monthly anniversary of such grant date, until it is fully vested and exercisable on January 20, 2028.